Patient | Age, years | Sex | Karyotypea | Prognosisb | Previous therapyc | Leukocytes/nL | Spontaneous apoptosisd | VPA effecte |
---|---|---|---|---|---|---|---|---|
1 | 75 | M | Normal | p | + | 44 | + | 0 |
2 | 71 | F | 13q- | g | − | 16 | 0 | ++ |
3 | 79 | F | NA | g | − | 122 | 0 | + |
4 | 56 | F | 13q- | g | − | 146 | + | ++ |
5 | 74 | M | NA | g | − | 16 | 0 | ++ |
6 | 75 | M | 13q- | p | + | 261 | + | ++ |
7 | 67 | M | Normal | g | − | 79 | ++ | ++ |
8 | 75 | M | 13q- | p | + | 128 | + | + |
9 | 72 | M | Normal | p | − | 58 | + | + |
10 | 64 | M | 13q-, 17p- | p | + | 83 | + | + |
11 | 68 | F | Normal | p | + | 98 | + | ++ |
12 | 75 | M | + 12 | g | − | 27 | 0 | 0 |
13 | 57 | M | Normal | g | + | 278 | 0 | ++ |
14 | 71 | M | NA | p | + | 11 | + | ++ |
15 | 72 | F | 13q- | g | − | 19 | + | ++ |
16 | 81 | F | NA | p | − | 385 | ++ | ++ |
17 | 59 | F | 13q- | g | − | 43 | ++ | ++ |
18 | 68 | F | NA | g | − | 50 | 0 | ++ |
19 | 54 | M | Normal | g | − | 53 | 0 | + |
20 | 66 | M | NA | p | − | 61 | ++ | ++ |
21 | 65 | M | +12 | g | − | 35 | ++ | ++ |
22 | 67 | M | +12, 17p- | p | − | 81 | 0 | + |
23 | 67 | M | +12 | p | − | 43 | + | ++ |
24 | 66 | M | +12 | g | − | 45 | 0 | ++ |
25 | 66 | M | 13q-, 11q- | g | − | 188 | 0 | ++ |
26 | 73 | M | 17p- | p | − | 87 | + | ++ |
27 | 73 | M | 13q- | g | − | 55 | 0 | + |
28 | 41 | M | Normal | p | − | 68 | ++ | ++ |
29 | 65 | F | Normal | g | − | 12 | + | ++ |
30 | 75 | M | 13q-, 11q- | g | − | 39 | + | + |